Samsung Bioepis will be unable to sell Eticovo, a biosimilar of autoimmune disease treatment, Enbrel (Ingredient: etanercept), in the U.S. until 2029 as the company lost a patent lawsuit with its developer Immunex.According to industry insiders, the New Jersey district court ruled in favor of Amgen,
Big Pharma is finding it hard to keep up with challenges from biosimilar makers, including Korean companies, rapidly penetrating the global market dominated by original drugs, industry watchers said Friday.The rheumatoid arthritis treatment market is a case in point, where originals’ sales have cont
BIOnSYSTEMS’ new immunotherapy candidate BNS001 has been selected for government support for the second national new drug development project in 2021, the company said Wednesday.BNS001 is a dual-function protein immunotherapy candidate, in which “mutant-type Fc” with better durability in the blood i
TiumBio is working on various pipelines, including an anticancer drug inhibiting both TGF-β and VEGFR-2, an endometriosis drug, and hemophilia treatment.The market’s expectation for TiumBio is increasing because global trials of the company’s experimental drugs are expected to progress swiftly.Monda
Celltrion said that the Peruvian Drug Administration has granted conditional approval for Regkirona (ingredient: regdanvimab).The Peruvian Drug Administration is an organization that performs a function similar to that of the Ministry of Food and Drug Safety (MFDS), and all medicines distributed in
Celltrion’s Covid-19 antibody therapy Regkirona (ingredient: regdanvimab) received official authorization from the European Commission (EC) on Friday.The formal approval came just a day after the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended
Roche Diagnostics Korea's CustomBiotech team hosted an online meeting for researchers and companies developing mRNA technology on Thursday.More than 200 experts in charge of research and development (R&D) and production of mRNA technology shared their understanding of mRNA-based technology and futur
An Institute of Basic Sciences (IBS) research team has identified the principle that cancer suppressor protein ATAD5 regulates the termination of repairs on deoxyribonucleic acid (DNA) synthesis damaged by reactive oxygen.Researchers revealed that ATAD5 protein regulates DNA synthesis and finishes r
SK Biopharm said it launched a biotech company Ignis Therapeutics (Ignis), with 6 Dimensions Capital (6D), a healthcare investment firm based in Shanghai, to build a new drug development and commercialization platform in China.The establishment of Ignis in China led SK Biopharm to enter the top-4 gl
Samsung Biologics said it would participate in CPhI (Convention on Pharmaceutical Ingredients) Worldwide 2021 to promote its competitiveness and attract prospective customers.CPhI is the world's largest biopharmaceutical conference. This year’s event will be held on- and offline for the first time s
Lunit, an AI-driven medical device maker, said on Monday it has recruited international healthcare experts to reinforce its global business.The company hired many talented people from biotech firms, regulatory agencies, and medical institutions to strengthen global competitiveness, it said.Lunit rec
SK Bioscience said Friday that its Covid-19 vaccine candidate has shown excellent outcomes in phase 1 and 2 clinical trials.As the company has analyzed the results of previous clinical trials of its Covid-19 vaccine candidate and the ongoing phase 3 clinical trials, it expects to present the first h
LG Chem said that it is has received approval from the Ministry of Food and Drug Safety for the phase 1b and 2 clinical trials of LG34053, a next-generation osteoarthritis treatment.The company plans to accelerate the development of new drugs by designing clinical trials linked with phases 1 and 2.L
BioNote, which recently became the largest shareholder of EuBiologics, signed an agreement with EuBiologics to develop a universal Covid-19 vaccine that could fight virus variants.Industry watchers said the latest deal signaled BioNote might be seeking to acquire EuBiologics.EuBiologics said on Wedn
One after another, Korean biopharmaceutical companies are joining the club of 100 billion won ($85.1 million) in quarterly operating profit.Bolstering their growth in the global markets is differentiated competitiveness based on biosimilar production, contract development, and manufacturing organiza
ABL Bio, a company developing bispecific antibody platforms, said its cancer immunotherapy candidate ABL103 has been selected by the government as part of the national new drug development project.The state-funded program aims to help companies efficiently enter clinical studies for candidate substa
A research team at the Institute for Basic Science (IBS) has developed a novel antibody that normalizes damaged vessels in patients, offering a therapeutic antibody mechanism by identifying it in a three-dimensional molecular structure.The research team expects the study results to help develop ther
Alteogen said that it has found the optimal conditions for the subcutaneous injection formulation of recombinant human hyaluronidase (ALT-B4) and filed for a patent for the formulation.The company has continuously developed improved variants of hyaluronidase, an important component of subcutaneous i
Korean biotech companies are jumping into the drug contract manufacturing (CMO) business and increasing their production capacity to secure a stable source of income.Many bio ventures in the nation, such as Bioneer, Humedix, ViGenCell, and Genome & Company, have already begun expanding or preparing
Samsung Bioepis has completed the global phase 3 clinical trials of its SB12, a biosimilar drug of Soliris (ingredient: eculizumab), for treating paroxysmal nocturnal hemoglobinuria (PNH).The company received the last patient to end the clinical trials of SB12 and updated the study in clinicaltrials